You just read:

Artelo Biosciences And Stony Brook University Announce Worldwide License Agreement For Portfolio Of Fatty Acid Binding Protein Inhibitor Drug Candidates

News provided by

Artelo Biosciences, Inc.

Apr 18, 2018, 10:39 ET